Crenolanib is a type I tyrosine kinase inhibitor that inhibits mutant KIT D816 isoforms prevalent in systemic mastocytosis and core binding factor leukemia
Author:
|
Kampa-Schittenhelm, Kerstin Maria; Frey, Julia; Haeusser, Lara A.; Illing, Barbara; Pavlovsky, Ashly A.; Blumenstock, Gunnar; Schittenhelm, Marcus Matthias
|
Tübinger Autor(en):
|
|
Published in:
|
Oncotarget
(2017), Bd.
8,
H.
47,
S.
82897-82909
|
Verlagsangabe:
|
Impact Journals Llc
|
Language:
|
English
|
Full text:
|
http://dx.doi.org/10.18632/oncotarget.19970
|
ISSN:
|
1949-2553
|
DDC Classifikation:
|
570 - Life sciences; biology 610 - Medicine and health
|
Dokumentart:
|
Article
|
Show full item record
|